Arrow Mark Colorado Holdings LLC Forte Biosciences, Inc. Transaction History

Arrow Mark Colorado Holdings LLC

$8.04 Billion
Q1 2024

Shares

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2021 Nov 15, 2021	SELL	$2.96 - $36.67 $3.5 Million - $43.4 Million	-1,183,213 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$31.5 - $42.5 $6.66 Million - $8.98 Million	-211,351 Reduced 15.16%	1,183,213 $39.8 Million
Q1 2021 May 17, 2021	SELL	$25.01 - $40.24 $38.6 Million - $62.1 Million	-1,542,144 Reduced 52.51%	1,394,564 $47.8 Million
Q3 2020 Nov 16, 2020	BUY	$14.71 - $50.69 $43.2 Million - $149 Million	2,936,708 New	2,936,708 $142 Million

Others Institutions Holding FBRX

# of Institutions

34

Shares Held

19M

Call Options Held

1K

Put Options Held

0

Tybourne Capital Management (Hk) LTD Hong Kong, K3

3.62M
Shares

$1.88 Million
0.57% of portfolio
Perceptive Advisors LLC New York, NY

3.27M
Shares

$1.7 Million
0.05% of portfolio
Bvf Inc San Francisco, CA

2.98M
Shares

$1.55 Million
0.06% of portfolio
Cable Car Capital LLC San Francisco, CA

2.03M
Shares

$1.06 Million
1.95% of portfolio
Fred Alger Management, LLC New York, NY

1.84M
Shares

$956,261
0.01% of portfolio

About Forte Biosciences, Inc.

Ticker FBRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,340,300
Market Cap $10.6M
Description
Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. It is developing FB-102 program that addresses various autoimmune diseases, such as vitiligo and alopecia areata. The company is headquartered in Dallas, Texas.

More about FBRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Arrow Mark Colorado Holdings LLC, based on Form 13F filings with the SEC.

News

Stay updated on Arrow Mark Colorado Holdings LLC with notifications on news.